Skip to main content
. 2023 Oct 19;15(20):5064. doi: 10.3390/cancers15205064

Table 4.

Comparison of acute myeloid leukaemia (AML) measurable residual disease (MRD) by flow cytometric (FC-MRD) and molecular (Mol-MRD) methods using a 0.01% cutoff. Percentages are calculated within each row.

Mol MRD FC-MRD Total
Positive > 5%
(Relapse)
Positive Indeterminate Negative
Positive 1 (3%) 10 (30%) 8 (24%) 14 (43%) 33 (100%)
Negative 0 (0%) 16 (32%) 4 (8%) 30 (60%) 50 (100%)
Total 1 (1%) 26 (31%) 12 (15%) 44 (53%) 83 (100%)